{"id":"NCT04811664","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","briefTitle":"A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine","officialTitle":"A Randomized Controlled Study to Assess SARS CoV-2 Infection, Viral Shedding, and Subsequent Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-03-24","primaryCompletion":"2021-12-30","completion":"2021-12-30","firstPosted":"2021-03-23","resultsPosted":"2023-07-27","lastUpdate":"2023-08-02"},"enrollment":1923,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["SARS-CoV-2 Infection"],"interventions":[{"type":"BIOLOGICAL","name":"Moderna COVID-19 Vaccine","otherNames":["mRNA-1273"]}],"arms":[{"label":"Immediate Vaccination","type":"EXPERIMENTAL"},{"label":"Standard of care","type":"EXPERIMENTAL"},{"label":"Vaccine Declined","type":"NO_INTERVENTION"}],"summary":"The purpose of this study is to assess SARS CoV-2 infection, viral shedding, and subsequent potential transmission in individuals immunized with the Moderna COVID-19 vaccine.","primaryOutcome":{"measure":"Efficacy of Moderna COVID-19 Vaccine Against SARS-CoV-2 Infection","timeFrame":"Measured through Month 4 study visit","effectByArm":[{"arm":"Immediate Vaccination","deltaMin":12.2,"sd":null},{"arm":"Standard of Care","deltaMin":31.8,"sd":null},{"arm":"Vaccine Declined","deltaMin":89.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":12},"locations":{"siteCount":51,"countries":["United States"]},"refs":{"pmids":["39182315","38023544"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}